aftobetin
Phase 2- Indications
- Alzheimer's disease
Company intelligence / Profile preview
Cognoptix
Marlborough, Massachusetts, United Statescognoptix.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Cognoptix has developed a non-invasive laser eye scanning diagnostic platform that detects beta amyloid proteins in the lens of the eye—a hallmark of Alzheimer’s disease. The technology combines an optical scanner with a proprietary ophthalmic ointment to enable early diagnosis. Early clinical results have been positive, and the company aims to provide a quick, affordable test suitable for routine physician office use.
- The company continues to develop its platform and seeks partnerships with pharma companies for drug development support and patient monitoring in trials.
- No large-scale pivotal trial or commercial launch yet reported as of May 2025.
- Therapeutic areas
- Neurology
- Modalities
- Diagnostic device (laser eye scanning)ophthalmic diagnostic agent/ointment
- Industry
- Medical Imaging
02
Drug pipeline
1 asset03
Partnerships
Actively seeking strategic alliances with pharmaceutical partners and academic institutes; no specific major partnerships disclosed as finalized as of May 2025.
Beyond the preview
Go deeper on Cognoptix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cognoptix.